Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch

Bibliographic citation
In: Clinical and molecular hepatology, 24.2018, cmh.2018.0029, doi:10.3350/cmh.2018.0029

Event
Veröffentlichung
(where)
Frankfurt am Main
(who)
Universitätsbibliothek Johann Christian Senckenberg
(when)
2018
Creator
Mölleken, Christian
Ahrens, Maike
Schlosser, Anders
Dietz, Julia
Eisenacher, Martin
Meyer, Helmut E.
Schmiegel, Wolff
Holmskov, Uffe
Sarrazin, Christoph
Sørensen, Grith Lykke
Sitek, Barbara
Bracht, Thilo

URN
urn:nbn:de:hebis:30:3-484281
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:57 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Mölleken, Christian
  • Ahrens, Maike
  • Schlosser, Anders
  • Dietz, Julia
  • Eisenacher, Martin
  • Meyer, Helmut E.
  • Schmiegel, Wolff
  • Holmskov, Uffe
  • Sarrazin, Christoph
  • Sørensen, Grith Lykke
  • Sitek, Barbara
  • Bracht, Thilo
  • Universitätsbibliothek Johann Christian Senckenberg

Time of origin

  • 2018

Other Objects (12)

Direct-acting antivirals and visceral leishmaniasis: a case report

Direct-acting antivirals and visceral leishmaniasis: a case report

Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications

Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications

Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway

Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway

Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis

Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis

Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals

Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals

Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals

Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals

Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients

Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients

Secular trends in cryoglobulinemia mortality in the USA in the era of direct-acting antivirals

Secular trends in cryoglobulinemia mortality in the USA in the era of direct-acting antivirals

Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study

Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study

Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals

Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals

Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection

Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection

A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals

A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals

Related objects